NewTimeSpace News: On 27 August 2026, CHENGDU EXPWAY (01785.HK) announced that non-executive director Ms. Wu Haiyan resigned with immediate effect due to retirement, also ceasing her roles on three board committees; the Board proposed appointing Ms. Jiang Na as a non-executive director, subject to shareholders' approval; following Ms. Wu's departure, the audit committee fell below three members and the board's gender diversity no longer complies with the Listing Rules, with the Company aiming to fill vacancies within three months.
NewTimeSpace News: On 27 August 2026, HK ROBOTICS (00370.HK) announced the latest progress of its cooperation with Danta Robotics: three core objectives including the establishment of the joint venture, IP licensing and operation team formation have been basically achieved, with the exclusive license for the Danta Cloud Brain expiring in September 2028; robotics and computing power revenue for the year ended 31 March 2026 was approximately HKD 169.6 million, of which about 83% related to products using Danta's licensed IP; the 2025 revenue target was not fully achieved due to delays, with the parties negotiating adjustments and the Group seeking to reduce its 49% stake in the joint venture; the Group is independently developing the "Hong Kong Robotics Cloud Brain" expected to be completed before September 2028, after which license fees will no longer be payable.
NewTimeSpace News: August 27, 2026, ZOOMLION(01157.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 27.14 billion, increased by 9.17% YoY
NewTimeSpace News: August 27, 2026, JW THERAP-B(02126.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 111.35 million, increased by 4.71% YoY.
NewTimeSpace News: On 27 August 2026, SSY GROUP (02005.HK) announced that it has obtained NMPA production registration approvals for gadobutrol injection (7.5ml: 4.5354g, Category 4 chemical drug) and indocyanine green for injection (25mg, Category 3 chemical drug), both deemed to have passed consistency evaluation; the products are used for contrast-enhanced MRI examinations and the diagnosis of liver diseases respectively, and together with the Group's already-registered APIs complete its integrated layout, supporting expansion into the medical imaging and critical care markets.
NewTimeSpace News: On 27 August 2026, IB SETTLEMENT (00147.HK) announced at the request of the Exchange that, in response to an increase in the share price and trading volume, the Board is not aware of any reasons for the fluctuation; the Company is in preliminary discussions with an independent third party over a potential investment opportunity in the technology sector, with terms not yet finalized and no formal agreement signed, and the potential investment, if materialized, may constitute a discloseable transaction.
NewTimeSpace News: On 27 August 2026, LIVZON PHARMA (01513.HK) announced that its controlling subsidiary has received the NMPA Drug Registration Certificate for lecankitug injection (subcutaneous injection), with approval number Guoyao Zhunzi S20260065 valid until 24 August 2031; the drug is China's first independently developed IL-17A/F dual-target biologic for adult patients with moderate-to-severe plaque psoriasis, with Phase III data showing superiority over secukinumab control in onset of action, lesion clearance and long-term efficacy, and cumulative R&D investment of approximately RMB 223.31 million.
NewTimeSpace News: On 27 August 2026, SUN KONG HLDGS (08631.HK) announced that it received resumption guidance from HKEX on 24 August 2026, covering six conditions including publication of outstanding financial results, independent forensic investigation and internal control review; trading has been suspended since 2 July 2026, and if trading is not resumed by 1 July 2027, HKEX may proceed with the cancellation of the Company's listing.
NewTimeSpace News: On 27 August 2026, CSPC PHARMA (01093.HK) announced that its SYH2092 injection, an amylin receptor agonist, has been approved by the NMPA to conduct clinical trials in China; preclinical studies showed higher target agonistic activity, significant weight loss effects and durable maintenance versus multiple amylin analogues in development, with synergistic weight loss when combined with the Group's GLP-1/GIP receptor dual biased agonist, potentially benefiting weight management in obesity and glycemic control in adult T2DM patients.
NewTimeSpace News: On 27 August 2026, FOSUN PHARMA (02196.HK) announced that, pursuant to the general mandate granted at the annual general meeting and other meetings, it repurchased 217,000 H shares in the open market on the same day, at an average price of HKD 16.53 per share and a total amount of approximately HKD 3.587 million, with the highest and lowest prices at HKD 16.59 and HKD 16.45 respectively; the repurchased shares will be held as treasury shares with use including but not limited to cancellation.
NewTimeSpace News: On 27 August 2026, CCB (00939.HK) announced that the 2025 annual general meeting held on 26 June 2026 approved the election of Mr. Yang Qiang as an independent non-executive director, and that the National Financial Regulatory Administration has approved his qualification, with Mr. Yang officially assuming office.
NewTimeSpace News: On 27 August 2026, the three major Hong Kong indices retreated in volatile trading, with the Hang Seng Index down 0.34% to 25,565.74 points, the Hang Seng TECH Index down 0.13%, and turnover at HKD 233.5 billion. Driven by NVIDIA's better-than-expected results, AI hardware stocks strengthened, with YOFC up 10.31% and KB LAMINATES up 10.51%; the twin large-language-model stocks shone, with Z.AI up 12.62% and MINIMAX up 3.83%. BIDU-SW gained 5.34% as its dual primary listing takes effect on 1 September, lifting inclusion expectations. Southbound capital recorded net buying of HKD 3.18 billion. ZJ INNOLIGHT was officially added to Stock Connect; SHEIN-W's public offering closed, with listing set for 1 September.
NewTimeSpace News: On 27 August 2026, TWINTEK (06182.HK) announced that substantial shareholder Mr. Li Haoyuan disposed of 90,000,000 shares of the Company on the same day, representing approximately 11.25% of the issued share capital; following the disposal, Mr. Li no longer holds any shares and ceases to be a substantial shareholder.
NewTimeSpace News: August 27, 2026, KONG SUN HOLD(00295.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 150.88 million, decreased by 6.28% YoY.
NewTimeSpace News: On 27 August 2026, GUANGDONG INV (00270.HK) announced that its indirectly wholly-owned subsidiary Guangdong Yuehai Water Investment Co., Ltd. has completed the issuance of the first tranche of corporate bonds with an aggregate principal of RMB 500,000,000, a 3-year term, a coupon rate of 1.49% and a subscription multiple of 7.42, with interest accruing from 27 August 2026; proceeds will be used to repay existing borrowings and replenish working capital.
NewTimeSpace News: On 27 August 2026, S HARBOURHOLD (01663.HK) announced that Chairman and substantial shareholder Mr. Wang Linbing purchased 9,258,000 ordinary shares of the Company in the open market on the same day, at an average price of approximately HKD 0.052 per share and a highest price of HKD 0.053 per share.
